Schedule 13G ownership disclosure

REGULUS THERAPEUTICS INC

Security class unavailable · CUSIP: 75915K200

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,503,642
Percent of class
5.8300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001040188-22-000002
Form type
SC 13G/A
Filer
Regulus Therapeutics Inc.
CIK
CIK 1505512
Filed
Jan 04, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub